decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Answer_Book / Drugs_Injections / Oral Anti-Cancer Drugs 10 2007
Subscribe or sign in to view the full article.
Article Overview
This article is a drug-reference update for oral anti-cancer medications, organized as a product list with manufacturer, strength, NDC, and allowable amount information. It is useful for billing, reimbursement lookup, and identifying active NDCs associated with this 2007 update. The content is directed to coding, billing, and reimbursement professionals who need a current product-level reference rather than clinical guidance.
Why This Topic Matters
It helps users verify which oral oncology drug products were included in this quarterly update and compare the listed NDCs and allowables against their own billing or inventory references.
Article Sections
-
Oral Anti-Cancer Drugs
A product-level list of oral oncology medications with manufacturer, strength, NDC, and allowable information. The section also includes update timing and notes about the status of listed NDCs.
What You Will Learn
- Which oral anti-cancer drug products are included in the update
- What product-level reference details are provided for each listing
- How the article is organized as a reimbursement and inventory reference
- What timing and coverage-related notes accompany the update
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Pharmacy billing personnel
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com